Clinical trial
EArly Discharge After Transradial Stenting of CoronarY Arteries: The EASY Study
NCT00169819 · Laval University, Other · Completed
Key facts
| NCT number | NCT00169819 |
|---|---|
| Title | EArly Discharge After Transradial Stenting of CoronarY Arteries: The EASY Study |
| Official title | A Randomized Trial Comparing Same Day Discharge and a Single Bolus of Abciximab to Overnight Hospitalization and Bolus + Perfusion Abciximab After Uncomplicated Trans-Radial Coronary Artery Stenting |
| Lead sponsor | Laval University, Other |
| Collaborators | Eli Lilly and Company Industry Bristol-Myers Squibb |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease, Ischemia |
| Intervention type | Drug |
| Interventions | Abciximab |
| Enrollment | 1,000 |
| Start date | Oct 1, 2003 |
| Completion | Apr 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Feb 26, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: